Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Declines By 55.6%

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 6,349 shares, a decrease of 55.6% from the June 30th total of 14,284 shares. Based on an average daily volume of 45,861 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy”.

Nihon Kohden Trading Up 2.8%

Shares of NHNKY opened at $10.14 on Thursday. The company has a market cap of $1.70 billion, a price-to-earnings ratio of 17.19 and a beta of 0.39. Nihon Kohden has a 1-year low of $8.12 and a 1-year high of $14.21. The company’s fifty day simple moving average is $9.05 and its 200 day simple moving average is $9.84.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The firm had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. As a group, research analysts forecast that Nihon Kohden will post 0.6 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.